Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis
The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.
North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.
Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.
Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.
Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021.The report also entails major drivers and challenges of neuromodulation market.
Neuromodulation Market: Segmentation
Neuromodulation market is classified on the basis of technology, application, company and geography.
Based on Technology, Neuromodulation market can be segmented as follows:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Other Technologies
Based on Application, Neuromodulation market can be segmented as follows:
Chronic Pain
Parkinson’s Disease
Urinary Fecal Incontinence
Refractory Epilepsy
Essential Tremor
Dystonia
Gastroparesis
Treatment Resistant Depression(TRD)
Obsessive Compulsive Disorder(OCD)
Other Applications
Based on Geography, Neuromodulation market can be segmented as follows:
North America
Europe
Asia Pacific
Latin America
Rest of the World (ROW)
Based on Company, Neuromodulation market can be segmented as follows:
Medtronic
Boston Scientific
St Jude Medical
Liva Nova(Cyberonics)
Nevro
DPI Research & Marketing Solutions
95/9, Kishangarh
Vasant Kunj
New Delhi 110070
India
Contact:Sajid Jamal
Presscontaact:seo@dpiresearch.com
DPI Research & Marketing Solutions
95/9, Kishangarh
Vasant Kunj
New Delhi 110070
India
Contact:Sajid Jamal
Presscontaact:seo@dpiresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis here
News-ID: 369098 • Views: …
More Releases from DPI Research
China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forec …
China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)
As per DPI Research latest published report, the China Non-Invasive Prenatal Testing (NIPT) market size was valued at US$ 608 Million in 2023 and it is forecasted to reach US$ 1,083 Million by the year end of 2032. China non invasive prenatal testing (NIPT) market compound annual growth rate will be 7.04% from 2024 to 2032.
This new…
India Outbound MICE Tourism Market worth US$ 13.4 Billion by 2030|DPI Research
DPI Research has published a new research report titled "India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) Tourism Market 2023: Outlook, Trends, Opportunities and Forecasts to 2031" in its research database.
According to the latest research study 2023, India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) tourism market size is expected to reach US$ 13.4 billion by 2031.
The Indian Outbound Tourism (MICE) is experiencing significant growth due to a…
India's Outbound Tourism Market Is Expected To Boost By 11% CAGR Between 2023 An …
[230+ Pages Latest Report] According to a market research study published by DPI Research, India's outbound tourism market size is expected to reach $60 billion by 2031, growing at a CAGR of 10.9% over the forecast period 2023-2031.
Rising personal income levels and greater accessibility will enable international travel for a greater proportion of India's population. India's sizable global diasporas and international student body will continue to be a pull factor…
United States Non Invasive Prenatal Testing (NIPT) Market Size 2023 - 2031 | Key …
The research report on the NIPT Test Market, released by DPI Research, offers a comprehensive analysis of the US industry. The report provides valuable insights into the market's size, share, and industry trends, along with a detailed breakdown of products and services. It presents key statistics regarding the market's status, growth factors, and upcoming trends. The report also discusses the potential industrial opportunities and growth scenarios for the NIPT Test…
More Releases for Neuromodulation
Internal Neuromodulation Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Internal Neuromodulation market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report is…
Neuromodulation Devices Market 2022 | Detailed Report
The Neuromodulation Devices research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,…
Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected…
Neuromodulation Market Thriving Worldwide $11,717 Million By 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022.
For More Info, Get PDF Sample : http://bit.ly/2BciOaa
Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections…
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027.
Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027
Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand…
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum…